Compare Crown Castle International Corp (CCI) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crown Castle International Corp vs Johnson & Johnson — how do they compare? Crown Castle International Corp trades at $74.06 (market cap $31.33B), while Johnson & Johnson trades at $260.71 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 20× Crown Castle International Corp's market cap, and Crown Castle International Corp pays the higher dividend (5.77%). Which is the better fit depends on your goals.
| CCI | JNJ | |
|---|---|---|
Market Cap | $31.33B | $626.09B |
Sector | Real Estate | Health |
52-Week High | $103.79 | $267.24 |
52-Week Low | $73.61 | $172.78 |
Enterprise Value | $53.69B | $654.37B |
Dividend Yield | 5.77% | 2.06% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Crown Castle (CCI) trades at $74.06, up 0.61% today, near a one-year low. The stock shows a bearish technical trend but maintains a 5.5% dividend yield. Recent Q2 2026 earnings beat AFFO estimates, with organic growth of 3.9%, though revenue declined year-over-year. The company completed its transition to a pure-play U.S. tower operator after selling its fiber business.
Outlook is mixed: analyst consensus is split evenly between Buy and Hold with a $95.29 price target, suggesting 29% upside. Key risks include high debt levels (debt-to-asset ratio of 77.21% in 2025) and competitive pressure in the tower REIT sector. The current valuation appears discounted relative to historical multiples, offering potential for income-focused investors.
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
